ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
GlaxoSmithKline mulls respiratory exit to support big bet on cancer R&D
fiercebiotech
November 02, 2018GlaxoSmithKline may exit the respiratory business and pull back in other areas to commit more cash to cancer R&D, according to Axel Hoos. Hoos, GSK’s head of oncology,?... -
UK’s Enterprise Therapeutics raises ￡29m
pharmatimes
April 13, 2018Brighton, UK-based Enterprise Therapeutics has raised ￡29 million to help it advance its experimental therapies for respiratory diseases. -
AstraZeneca inks respiratory disease mRNA pact with Ethris
fiercebiotech
August 22, 2017AstraZeneca and Ethris are researching asthma, chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. -
AstraZeneca, MedImmune and Ethris to develop mRNA treatments for respiratory diseases
pharmaceutical-technology
August 22, 2017AstraZeneca, along with its global biologics research and development unit MedImmune, and German biotech Ethris have entered?a strategic research collaboration to develop stabilised non-immunogenic modified messenger ribonucleic acid (mRNA) therapies for
Pharma Sources Insight January 2025
